Victor P. Letyagin

Victor P. Letyagin

Auto-generated profile, based on publicly available information

Victor P. Letyagin

Blokhin National Medical Research Center of Oncology

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2020 in Current Pediatrics
Verified
Journal Article
Open access
PDF file
IVIrina V. Visotskaya
Irina V. Visotskaya
VLVictor P. Letyagin
Victor P. Letyagin
IVIgor K. Vorotnikov
Igor K. Vorotnikov
EKElena A. Kim
Elena A. Kim
VKVladislav Yu. Kirsanov
Vladislav Yu. Kirsanov
SPSvetlana B. Polikarpova
Svetlana B. Polikarpova
Diseases of the mammary glands (usually benign) have the incidence of 5–12% in the structure of children diseases. Breast cancer is extremely rare (less than 1% of all breast diseases). This review contains actual data on the most common focal pathology of mammary glands in teenage girls such as: focal hyperplasia, cysts and breast fibroepithelial tumors. Clinical manifestations, morphological picture and diagnostics are described. Main approaches to treatment of patients with focal pathology of mammary glands are defined. The presented data is crucial for timely diagnosis of focal pathology of mammary glands, selection of examination tactics, management and necessary measures for oncological diseases prevention in children.

6 September 2019 in Tumors of female reproductive system
Verified
Journal Article
Open access
PDF file
IVI. V. Vуsotskaya
I. V. Vуsotskaya
VLV. P. Letyagin
V. P. Letyagin
IVI. K. Vorotnikov
I. K. Vorotnikov
VKV. U. Kirsanov
V. U. Kirsanov
IGI. A. Gladilina
I. A. Gladilina
EKE. A. Kim
E. A. Kim
The research provided includes analysis of the current state of the problem on the use of oral contraceptives and menopausal hormone therapy. These therapeutic options were evaluated in terms of their importance for the risk of breast cancer. The possibility of using these drugs in a cohort of high-risk patients (women with family history of breast cancer) and in the group of patients with benign pathology was analyzed as well. Modern trends of menopausal hormone therapy prescription in different clinical situations were determined.